학술논문
Combined therapy with ibrutinib and bortezomib followed by ibrutinib maintenance in relapsed or refractory mantle cell lymphoma and high-risk features: a phase 1/2 trial of the European MCL network (SAKK 36/13)
Document Type
Article
Author
Novak, U.; Fehr, M.; Driessen, C.; Schär, S.; Scheibe, B.; Gadient, S.; Eckhardt, K.; Dreyling, M.; Schmidt, C.; Derenzini, E.; Zander, T.; Hess, G.; Mey, U.; Ferrero, S.; Mach, N.; Boccomini, C.; Böttcher, S.; Voegeli, M.; Cairoli, A.; Ivanova, V.-S.; Menter, T.; Dirnhofer, S.; Zucca, E.; Renner, C.
Source
In: eClinicalMedicine . (eClinicalMedicine, October 2023, 64)
Subject
Language
English
ISSN
25895370